4.6 Review

Phenotypes and Genotypes of Inherited Disorders of Biogenic Amine Neurotransmitter Metabolism

Related references

Note: Only part of the references are listed.
Article Neurosciences

A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the SLC18A2 gene

Hongyin Zhai et al.

Summary: This case describes a 6-month-old male infant diagnosed with infantile parkinsonism-dystonia-2, caused by a mutation in the SLC18A2 gene resulting in brain dopamine-serotonin vesicular transport disease. The father carried the same mutation in a heterozygous state. Treatment with a dopamine agonist improved some symptoms.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2023)

Article Genetics & Heredity

Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals

Ken Saida et al.

Summary: This study evaluated the genotype-phenotype correlations in individuals with biallelic SLC18A2 variants. It was found that affected individuals typically showed global developmental delay, hypotonia, movement disorders, and autonomic nervous system involvement. Some patients responded well to dopamine agonists, while others showed milder symptoms and prolonged survival even without treatment.

GENETICS IN MEDICINE (2023)

Review Endocrinology & Metabolism

Stroke and stroke-like episodes in inborn errors of metabolism: Pathophysiological and clinical implications

Mario Mastrangelo et al.

Summary: Inborn errors of metabolism can cause stroke or stroke-like episodes, with a wide range of diseases and acute metabolic decompensations. Early diagnosis is crucial as symptomatic treatments and disease modifying therapies may be available to prevent or treat strokes.

MOLECULAR GENETICS AND METABOLISM (2022)

Article Biotechnology & Applied Microbiology

Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency

Chun-Hwei Tai et al.

Summary: Gene therapy with eladocagene exuparvovec in patients with aromatic L-amino acid decarboxylase deficiency leads to sustained and meaningful benefits, including improvements in motor and cognitive function, increased dopamine production, symptom relief, improved growth, and enhanced quality of life for patients and caregivers.

MOLECULAR THERAPY (2022)

Review Clinical Neurology

Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review

Anne Weissbach et al.

Summary: By analyzing a large number of DRD patients and asymptomatic GCH1 mutation carriers, specific phenotypic and biochemical characteristics were identified, which can aid in the rapid diagnosis and initiation of treatment.

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

Genetic landscape of Segawa disease in Spain. Long-term treatment outcomes

Joaquin A. Fernandez-Ramos et al.

Summary: This study provides a detailed phenotypic-genotypic description of Segawa disease in Spain, identifying 5 novel mutations and supporting the hypothesis of a founder effect of p. Q89* in Andalusia. Insights into phenotypes and long-term treatment responses were also provided, which may aid in early recognition and therapeutic management.

PARKINSONISM & RELATED DISORDERS (2022)

Article Endocrinology & Metabolism

Spectrum of DDC variants causing aromatic L-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations

Nastassja Himmelreich et al.

Summary: The research aims to identify pathogenic DDC variants in AADC deficiency, classify and curate variants of unknown significance, and improve the diagnostic accuracy of genetic testing for this condition. By combining in silico variant interpretation tools, structural 3D modeling, and comparative analysis, the current interpretation recommendations for DDC variants have been enhanced.

MOLECULAR GENETICS AND METABOLISM (2022)

Article Clinical Neurology

Volumetric study of brain MRI in a cohort of patients with neurotransmitter disorders

Chiara Alfonsi et al.

Summary: This study describes cerebral volumetric findings in a group of Spanish patients with neurotransmitter disorders. Regardless of the specific disease, patients showed a smaller total cerebral tissue volume, which was associated with clinical severity. The study also identified characteristic volumetric deficit patterns that could be important for diagnosis and prognosis of the disease.

NEURORADIOLOGY (2022)

Article Biochemistry & Molecular Biology

Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene

Ainhoa Martinez-Pizarro et al.

Summary: We report the identification of two new splicing variants of 6-pyruvoyl-tetrahydropterin synthase in a patient with tetrahydrobiopterin deficiency. These variants were found to cause the inclusion of abnormal pseudoexons, leading to hyperphenylalaninemia and monoamine neurotransmitter deficiency. Antisense oligonucleotides were designed to correct the aberrant pseudoexon inclusion, demonstrating the therapeutic potential of this approach.

NUCLEIC ACID THERAPEUTICS (2022)

Article Clinical Neurology

Long-term neurological and psychiatric outcomes in patients with aromatic L-amino acid decarboxylase deficiency

Filippo Manti et al.

Summary: Patients with AADCD exhibit intellectual disability and psychiatric disorders, along with movement disorders such as parkinsonism-dystonia, dysarthria, and oculogyric crises. CSF levels of 5-HIAA and HVA at diagnosis significantly impact adaptive behavior and executive function performance. Homozygous DDC pathogenetic variants are associated with lower CSF levels and higher Parkinson's disease rating scale scores.

PARKINSONISM & RELATED DISORDERS (2022)

Review Endocrinology & Metabolism

Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency

Tessa Wassenberg et al.

Summary: DBH deficiency is a rare genetic disorder characterized by severe orthostatic hypotension, which can be treated with L-DOPS. Patients show significant improvement with L-DOPS treatment, but orthostatic hypotension, renal function, anemia, and hypomagnesemia remain partially resolved.

JOURNAL OF INHERITED METABOLIC DISEASE (2021)

Review Endocrinology & Metabolism

Epilepsy in inherited neurotransmitter disorders: Spotlights onpathophysiology and clinical management

Mario Mastrangelo

Summary: Inborn errors of neurotransmitter metabolism are rare disorders that primarily impact neurotransmitter synthesis, breakdown, or transport. Epilepsy may be a main clinical symptom in some cases, while it is less common in others. The review analyzes the mechanisms, phenotypes, and clinical management of epilepsy in primary and secondary inherited disorders of neurotransmitter metabolism.

METABOLIC BRAIN DISEASE (2021)

Review Clinical Neurology

Parkinsonism in children: Clinical classification and etiological spectrum

Vincenzo Leuzzi et al.

Summary: Infantile- and childhood-onset parkinsonism is a rare condition primarily caused by genetic alterations, in contrast to Parkinson's disease which is more common in adults. Clinical criteria for parkinsonism in early stages of neuromotor development lack consensus. Proposed classification is based on age at presentation, clinical features, outcome, and etiological background, with subgroups for different presentations impacted by immature brain. Genetic conditions can cause diverse parkinsonisms in children, with new emerging conditions arising from multiple genetic lesions.

PARKINSONISM & RELATED DISORDERS (2021)

Article Endocrinology & Metabolism

Brain MR patterns in inherited disorders of monoamine neurotransmitters: An analysis of 70 patients

Oya Kuseyri Hubschmann et al.

Summary: Inherited monoamine neurotransmitter disorders (iMNDs) are rare disorders with a wide range of clinical manifestations, including neuronal dysfunction and vascular abnormalities evident on brain MRIs. Analyzing brain MRIs of patients with iMNDs revealed specific patterns of chronic neurological effects and repetitive injury to cerebral and cerebellar watershed areas, particularly in patients with dihydropteridine reductase deficiency (DHPRD). These findings could aid in the differential diagnosis of unknown neurological disorders in children and the monitoring of iMNDs.

JOURNAL OF INHERITED METABOLIC DISEASE (2021)

Article Biochemical Research Methods

Simultaneous determination of 5-hydroxytryptophan and 3-O-methyldopa in dried blood spot by UPLC-MS/MS: A useful tool for the diagnosis of L-amino acid decarboxylase deficiency

Emanuele Di Carlo et al.

Summary: The study developed and validated a fast and specific diagnostic tool for detecting 5-HTP and 3OMD, improving the specificity and sensitivity for the biochemical diagnosis of AADC deficiency.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)

Article Endocrinology & Metabolism

Detection of 3-O-methyldopa in dried blood spots for neonatal diagnosis of aromatic L-amino-acid decarboxylase deficiency: The northeastern Italian experience

Alberto Burlina et al.

Summary: The study introduces a rapid new method to identify AADC deficiency using reagents and equipment widely used in neonatal screening programs. The analysis of 3-OMD concentrations in healthy newborns and patients receiving L-Dopa treatment demonstrated the effectiveness of the method, laying the foundation for potential deployment in expanded neonatal screening to enable early diagnosis for effective treatment.

MOLECULAR GENETICS AND METABOLISM (2021)

Review Health Care Sciences & Services

Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia-A Focus on Tyrosine Hydroxylase Deficiency

Gyrid Nygaard et al.

Summary: Dopa-responsive dystonia (DRD) is a rare movement disorder linked to defective dopamine synthesis, mainly associated with mutations in the GCH1 gene. However, some patients do not respond well to L-DOPA treatment, especially in severe cases of TH deficiency. This highlights the need for more effective and personalized treatment options.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Review Endocrinology & Metabolism

Molecular and metabolic bases of tetrahydrobiopterin (BH4) deficiencies

Nastassja Himmelreich et al.

Summary: Tetrahydrobiopterin (BH4) deficiency, caused by genetic variants in genes involved in cofactor biosynthesis and recycling, leads to reduced cofactor levels and potential systemic hyperphenylalaninemia and neurological sequelae. The clinical impact of these genetic variants vary and are crucial for genetic counseling and precision medicine development.

MOLECULAR GENETICS AND METABOLISM (2021)

Article Multidisciplinary Sciences

BH4-deficient hyperphenylalaninemia in Russia

Polina Gundorova et al.

Summary: This study identified a cohort of 30 Russian patients with HPABH(4), predominantly HPABH(4)A type, with defined mutation spectrum for the PTS gene including common variants and novel variants. The estimated prevalence of HPABH(4) in Russia is lower compared to European countries, China, and Saudi Arabia. These results emphasize the importance of introducing differential diagnostics for HPABH(4) into neonatal screening practice.

PLOS ONE (2021)

Article Cell Biology

Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism

Joanne Ng et al.

Summary: Most inherited neurodegenerative disorders are currently incurable, with precision medicine offering potential solutions. DTDS patients suffer from early hyperkinesia and progressive parkinsonism, with no effective treatments available for the condition.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Biology

Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia

Jenny Aguilar et al.

Summary: Parkinson's disease is a progressive neurodegenerative disorder affecting millions worldwide. The study of dopamine transporter deficiency syndrome has provided insights into the molecular mechanisms underlying disease pathology and potential links to Parkinson's disease and Parkinsonism-dystonia. Through molecular modeling and simulations, researchers have identified a specific mutation in the dopamine transporter that disrupts its function, leading to impaired dopamine neurotransmission and associated motor deficits.

ELIFE (2021)

Article Endocrinology & Metabolism

Assessment of intellectual impairment, health-related quality of life, and behavioral phenotype in patients with neurotransmitter related disorders: Data from the iNTD registry

Mareike Keller et al.

Summary: Inherited disorders of neurotransmitter metabolism can impact intelligence, quality of life, and behavior of patients, leading to symptoms such as lowered IQ, behavioral abnormalities, and anxiety. Different types of neurotransmitter deficiencies result in different manifestations, with patients with BH4 deficiencies showing higher IQ and better quality of life.

JOURNAL OF INHERITED METABOLIC DISEASE (2021)

Article Endocrinology & Metabolism

DNACJ12 deficiency in patients with unexplained hyperphenylalaninemia: two new patients and a novel variant

Kismet Ciki et al.

Summary: DNAJC12 deficiency, in addition to tetrahydrobiopterin deficiencies and phenylalanine hydroxylase deficiency, can account for 10% or more cases of unexplained hyperphenylalaninemia, with a broad phenotypic spectrum and possible beneficial effects from early diagnosis and treatment.

METABOLIC BRAIN DISEASE (2021)

Article Multidisciplinary Sciences

Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons

Toni S. Pearson et al.

Summary: AADC deficiency is a rare genetic disorder characterized by deficient synthesis of dopamine and serotonin. In a clinical trial, delivery of AAV2-hAADC to the midbrain in children with AADC deficiency was found to be safe and led to clinical improvements in symptoms and motor function. The study demonstrated potential for midbrain gene delivery as a feasible and safe treatment approach for AADC deficiency.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines

Oya Kuseyri Huebschmann et al.

Summary: Inherited disorders of neurotransmitter metabolism are rare neurometabolic diseases characterized by movement disorders and developmental delay. A standardized evaluation of a registry of 275 patients from 42 countries highlights an evolving phenotypic spectrum of this disease group and factors influencing diagnostic processes.

NATURE COMMUNICATIONS (2021)

Article Clinical Neurology

Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Alba Trislan-Noguero et al.

Summary: This study conducted proteomic studies in cerebrospinal fluid samples of patients with monoamine defects and identified 4 novel biomarkers, shedding new light on the consequences of early dopaminergic deprivation in the developing brain.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Prevalence of Aromatic L-Amino Acid Decarboxylase Deficiency in At-Risk Populations

Keith Hyland et al.

PEDIATRIC NEUROLOGY (2020)

Article Endocrinology & Metabolism

AADCdeficiency from infancy to adulthood: Symptoms and developmental outcome in an international cohort of 63 patients

Toni S. Pearson et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2020)

Review Genetics & Heredity

Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies

Thomas Opladen et al.

ORPHANET JOURNAL OF RARE DISEASES (2020)

Article Endocrinology & Metabolism

Long-term clinical outcome of 6-pyruvoyl-tetrahydropterin synthase-deficient patients

Filippo Manti et al.

MOLECULAR GENETICS AND METABOLISM (2020)

Article Biochemistry & Molecular Biology

A Compound Heterozygote for GCH1 Mutation Represents a Case of Atypical Dopa-Responsive Dystonia

Subhajit Giri et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2019)

Review Endocrinology & Metabolism

Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook

Nastassja Himmelreich et al.

MOLECULAR GENETICS AND METABOLISM (2019)

Article Endocrinology & Metabolism

A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments

Xiaoling Jiang et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2019)

Review Endocrinology & Metabolism

DNAJC12 deficiency: A new strategy in the diagnosis of hyperphenylalaninemias

Nenad Blau et al.

MOLECULAR GENETICS AND METABOLISM (2018)

Letter Clinical Neurology

Successful Pregnancy in a Patient with L-Amino Acid Decarboxylase Deficiency: Therapeutic Management and Clinical Outcome

Mario Mastrangelo et al.

MOVEMENT DISORDERS CLINICAL PRACTICE (2018)

Editorial Material Clinical Neurology

NEUROMOTOR AND COGNITIVE OUTCOMES OF EARLY TREATMENT IN TYROSINE HYDROXYLASE DEFICIENCY TYPE B

Vincenzo Leuzzi et al.

NEUROLOGY (2017)

Letter Clinical Neurology

Exome sequencing results in identification and treatment of brain dopamine-serotonin vesicular transport disease

Matthias Rath et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Review Genetics & Heredity

Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency

Tessa Wassenberg et al.

ORPHANET JOURNAL OF RARE DISEASES (2017)

Article Genetics & Heredity

c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystonia

Ali S. Shalash et al.

NEUROLOGY-GENETICS (2017)

Article Genetics & Heredity

Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability

Yair Anikster et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2017)

Article Endocrinology & Metabolism

Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder

Jessie C. Jacobsen et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2016)

Review Clinical Neurology

Monoamine neurotransmitter disorders-clinical advances and future perspectives

Joanne Ng et al.

NATURE REVIEWS NEUROLOGY (2015)

Review Pediatrics

The Spectrum of Early Movement Disorders in Congenital Defects of Biogenic Amine Metabolism

Mario Mastrangelo et al.

JOURNAL OF PEDIATRIC NEUROLOGY (2015)

Article Medicine, Research & Experimental

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD

Freja H. Hansen et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Clinical Neurology

Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency

Roser Pons et al.

MOVEMENT DISORDERS (2013)

Letter Clinical Neurology

Transdermal rotigotine in the treatment of aromatic L-amino acid decarboxylase deficiency

Mario Mastrangelo et al.

MOVEMENT DISORDERS (2013)

Editorial Material Clinical Neurology

VERY EARLY PATTERN OF MOVEMENT DISORDERS IN SEPIAPTERIN REDUCTASE DEFICIENCY

Vincenzo Leuzzi et al.

NEUROLOGY (2013)

Article Medicine, General & Internal

Brain Dopamine-Serotonin Vesicular Transport Disease and Its Treatment

Jennifer J. Rilstone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Clinical Neurology

Sepiapterin reductase deficiency: A Treatable Mimic of Cerebral Palsy

Jennifer Friedman et al.

ANNALS OF NEUROLOGY (2012)

Article Clinical Neurology

A New Tyrosine Hydroxylase Genotype Associated With Early-Onset Severe Encephalopathy

Teresa Giovanniello et al.

JOURNAL OF CHILD NEUROLOGY (2012)

Article Endocrinology & Metabolism

An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia

Thomas Opladen et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2012)

Article Multidisciplinary Sciences

Genetic Mapping and Exome Sequencing Identify Variants Associated with Five Novel Diseases

Erik G. Puffenberger et al.

PLOS ONE (2012)

Article Clinical Neurology

Tyrosine Hydroxylase Deficiency in Taiwanese Infants

Ching-Shiang Chi et al.

PEDIATRIC NEUROLOGY (2012)

Review Clinical Neurology

The monoamine neurotransmitter disorders: an expanding range of neurological syndromes

Manju A. Kurian et al.

LANCET NEUROLOGY (2011)

Article Clinical Neurology

Cases of dopa-responsive dystonia (Segawa disease) in Estonia

Inga Talvik et al.

BRAIN & DEVELOPMENT (2010)

Article Clinical Neurology

Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients

I. Trender-Gerhard et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Article Endocrinology & Metabolism

Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency

Leandra Jaggi et al.

MOLECULAR GENETICS AND METABOLISM (2008)

Article Clinical Neurology

Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family

C. Wider et al.

PARKINSONISM & RELATED DISORDERS (2008)

Article Endocrinology & Metabolism

Unusually mild phenotype of AADC deficiency in 2 siblings

S. K. H. Tay et al.

MOLECULAR GENETICS AND METABOLISM (2007)

Article Clinical Neurology

Tyrosine hydroxylase deficiency presenting with a Biphasic Clinical Course

T. Giovanniello et al.

NEUROPEDIATRICS (2007)

Article Endocrinology & Metabolism

Molecular genetics of tetrahydrobiopterin (BH4) deficiency in the Maltese population

Rosienne Farrugia et al.

MOLECULAR GENETICS AND METABOLISM (2007)

Article Genetics & Heredity

Utility of MLPA in deletion analysis of GCH1 in dopa-responsive dystonia

Daniela Steinberger et al.

NEUROGENETICS (2007)

Article Endocrinology & Metabolism

Long-term outcome and neuroradiological findings of 31 patients with 6-pyruvoyltetrahydropterin synthase deficiency

L Wang et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2006)

Article Clinical Neurology

Misdiagnoses in children with doparesponsive dystonia

MMS Jan

PEDIATRIC NEUROLOGY (2004)

Article Clinical Neurology

Infantile parkinsonism-dystonia and elevated dopamine metabolites in CSF

BE Assmann et al.

NEUROLOGY (2004)

Review Clinical Neurology

Dopa-responsive dystonia - The story so far

O Bandmann et al.

NEUROPEDIATRICS (2002)